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Abstract
Background: Morphine is used in clinical practice as a highly effective painkiller as well as the drug of choice for
treatment of certain heart diseases. However, there is lack of information about its effect on protein expression in
the heart. Therefore, here we aimed to identify the presumed alterations in rat myocardial protein levels after
prolonged morphine treatment.
Methods: Morphine was administered to adult male Wistar rats in high doses (10 mg/kg per day) for 10 days.
Proteins from the plasma membrane- and mitochondria-enriched fractions or cytosolic proteins isolated from left
ventricles were run on 2D gel electrophoresis, scanned and quantified with specific software to reveal differentially
expressed proteins.
Results: Nine proteins were found to show markedly altered expression levels in samples from morphine-treaded
rats and these proteins were identified by mass spectrometric analysis. They belong to different cell pathways
including signaling, cytoprotective, and structural elements.
Conclusions: The present identification of several important myocardial proteins altered by prolonged morphine
treatment points to global effects of this drug on heart tissue. These findings represent an initial step toward a
more complex view on the action of morphine on the heart.
Keywords: rat myocardium, morphine, proteomics
Background
Morphine, a highly effective analgesic used for treatment
of different kinds of chronic pain states, may also exert
significant cardiovascular effects [1-3]. Moreover, under
certain conditions, this drug can be also implicated in
the acquisition of cardioprotection against ischaemia-
reperfusion injury [4-6]. However, the molecular
mechanisms and consequences of morphine actions on
the heart have not yet been fully elucidated. The major-
ity of studies dealing with morphine in the field of car-
diology are oriented on clinical usage of this drug and
current cardiovascular research has been limited to the
evaluation of factors or pathways believed to contribute
to its physiological action, such as δ-a n d-opioid
receptors, cyclooxygenase-2, inducible nitric oxide
synthase or reactive oxygen species [7-10]. Because of
great importance of this drug in clinical practice, and in
view of morphine unwanted effects on one side and car-
dioprotective potential on the other, investigation of its
impact on the heart at the molecular level deserves
more attention. A better understanding of the molecular
mechanisms involved in morphine actions will require
the evaluation of corresponding protein translation and
the integration of these findings into the overall context.
Proteomic technology allows for the examination of
global alterations in protein expression, and can provide
new insights into the cellular mechanisms involved in
cardiac dysfunction or other diseased states [11,12].
Apparently, this approach may also help to uncover the
possible broader effects of variable exogenous or endo-
genous stimuli on the heart muscle. Proteomics is there-
fore very useful to investigate the changes in protein
expression induced by various drugs or medicaments.
To date, several reports have been published about the
influence of morphine on protein expression in brain
tissue [13-15], but there is lack of information regarding
cardiac proteins under these conditions. Therefore, the
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of prolonged treatment of rats with high dose morphine
on myocardial protein expression. Application of differ-
ential proteomic analysis enabled us to identify nine
markedly altered proteins of different types in myocar-
dial preparations from morphine-treated rats.
Methods
Materials
Acrylamide and bis-acrylamide were from SERVA (Hei-
delberg, Germany), SYPRO Ruby stain from Molecular
Probes (Eugene, OR, USA) and nitrocellulose membrane
from Schleicher-Schuell (Erdmannhausen, Germany).
Immobiline DryStrips, Pharmalyte buffer, and secondary
anti-rabbit antibody labeled with horseradish peroxidase
were from GE Healthcare (Piscataway, NJ, USA) and
rabbit primary antibodies were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). All other
chemicals were from Sigma (St. Louis, MI, USA) and
they were of the highest purity available.
Animals and morphine treatment
Adult male Wistar rats were housed in groups of 3-4 in
Plexiglas chambers with food and water available ad
libitum and maintained on a 12-h light/dark cycle. All
animal experiments were conducted in accordance with
the Guide for the Care and Use of Laboratory Animals
as adopted by the National Institutes of Health (NIH
Publication No. 85-23, revised 1996). The rats were
injected intramuscularly with saline (CON group; n =
10) or morphine (10 mg/kg per day) (MOR group; n =
10) for 10 consecutive days. In some experiments,
naloxone (10 mg/kg per day) or a combination of nalox-
one and morphine (both 10 mg/kg per day) were admi-
nistered. Twenty four hours after the last dose, the
animals were sacrificed by cervical dislocation and the
hearts rapidly excised, dissected, snap frozen in liquid
nitrogen and stored at -80°C until use. In the withdrawal
experiments, samples of cardiac tissue were procured
from the animals sacrificed 3 days after the last dose of
morphine.
Cardiac tissue fractionation
Frozen samples of left ventricles were placed into 10
volumes of ice-cold TMES buffer (20 mM Tris, 3 mM
MgCl2, 1 mM EDTA and 0.25 M sucrose; pH 7.4) con-
taining the protease inhibitor cocktail (Roche Diagnos-
tics), cut in small pieces and homogenized in an Ultra-
Turrax blender (15 s). The resulting suspension was
further homogenized for 1 min in a glass homogenizer
with a motor-driven Teflon pestle, and then centrifuged
at 600 × g for 10 min at 4°C in order to remove large
tissue debris and nuclear fragments. The resulting post-
nuclear supernatant (PNS) was applied on the top of a
18% Percoll solution in TMES buffer and centrifuged at
60, 000 × g for 15 min. In this way, two layers contain-
ing opaque material were separated on the gradient.
The translucent top portion (~ 3 ml) of the gradient
containing soluble material was further centrifuged at
300, 000 × g to yield a clear supernatant cytosol frac-
tion. The upper layer enriched in plasma membranes
and the lower layer rich in mitochondria were separately
diluted in TME buffer and centrifuged at 150, 000 × g
for 1 h. The plasma membrane and mitochondrial pellet
was then resuspended in TME buffer, snap-frozen in
liquid nitrogen and stored in aliquots at -80°C until use.
Electrophoresis and immunoblotting
Protein samples solubilized in Laemmli buffer were
resolved on standard 10% polyacrylamide gels and trans-
ferred to nitrocellulose membrane. After blocking with
3% nonfat dry milk, the membranes were probed with
the appropriate antibodies and the immunodecorated
protein bands visualized by enhanced chemiluminis-
cence technique according to the manufacture’si n s t r u c -
tions (Pierce Biotechnology, Rockford, IL, USA). The
immunoblots were scanned and quantitatively analyzed
by ImageQuant™ TL software (Amersham Biosciences).
Proteomic analysis
Samples of all three fractions were precipitated with 6%
trichloracetic acid for 1.5 h on ice and then solubilized
in IEF buffer containing 7 M urea, 2 M thiourea, 4%
CHAPS, 1% DTT, 1% ampholines pH 3-10 and 0.01%
bromphenol blue. Samples of 100 μgp r o t e i no r3m g
protein (for MALDI-TOF MS/MS analysis) were applied
on immobilized pH 4-7 linear gradient strips. Proteins
were separated using the Multiphor II apparatus (150 V,
5 h; 500 V, 1 h; 3500 V, 12.5 h). Strips were equilibrated
for 15 min in 4 ml of EQ buffer (50 mM Tris, pH 6.8, 6
M urea, 30% glycerol, 2% SDS) containing 1% DTT, fol-
lowed by a second 15-min equilibration in EQ buffer
containing 4% iodacetamide and separated in the second
dimension on 10% SDS-polyacrylamide gels using the
Hoefer apparatus. Gels were stained with the fluorescent
dye SYPRO Ruby or colloidal Coomassie G-250 for
MALDI-TOF MS/MS and spot density was quantita-
tively analyzed by PDQuest software (Bio-Rad, Hercules,
CA, USA) as described previously [16]. Proteins with
altered expression were identified using a 4800 Plus
MALDI TOF/TOF Analyzer [16]. The obtained MS
spectra were searched against the rat IPI database by
Mascot v. 2.1 software (Matrix Science Ltd., London,
UK). Criteria for positive identification of proteins with
MS were set according to the scoring algorithm deli-
neated in Mascot http://www.matrixscience.com. A
minimum protein score of 60 (p < 0.05) were considered
as statistical values for identification.
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Protein concentration was determined by the BCA
method [17]. Master reference gels for 2D proteome
analysis were established by averaging the data of 12
replicas of each experimental group. Proteins isolated
from spots in 2D gels showing significant quantitative
differences (at least a 2-fold difference) between the
groups were subjected to mass spectrometric analysis.
Results and discussion
Although a series of proteins in the heart have been
shown to be qualitatively or quantitatively dysregulated
under various pathophysiological conditions, there is no
information about cardiac protein expression following
morphine administration. Therefore, this study was
designed to assess the presumed effect of prolonged
morphine treatment of rats on protein profiling in car-
diac tissue using a proteomics-based approach. The
hearts obtained from control and morphine-treated (10
mg/kg per day) animals did not differ in weight and did
not show any visual signs of gross pathology.
2D gel separation of myocardial proteins
Subcellular fractionation of tissue samples represents an
important first step prior to 2D gel-based proteomics
experiments, because it may reduce a high complexity
of these samples and improve detection of low abun-
dance proteins [18]. Therefore, left ventricles were
homogenized and subfractionated into a plasma mem-
brane-enriched fraction (PM), mitochondrial fraction
(MT) and cytosol (CS). To examine the specificity of
fractionation of heart tissue, immunoblot analysis was
carried out against known subcellular markers. Na, K-
ATPase (marker of PM), F1-ATPase (marker of MT),
and lactate dehydrogenase (marker of CS) were chosen
because of their well established roles in the respective
cellular fractions and immunoblots demonstrated the
appropriate subcellular location for these proteins (Fig-
ure 1). Whereas there was no apparent cross-contamina-
tion of the CS fraction with membrane-bound proteins,
the PM fraction was partially contaminated with MT
proteins and vice versa. Nevertheless, this partial cross-
contamination did not hamper subsequent proteomic
analyses.
All three fractions (PM, MT and CS) were resolved in
pH 4-7 IPG strips (IEF) and 10% polyacrylamide gels
(SDS-PAGE). After SYPRO Ruby staining, about 500
protein spots were detected on each two-dimensional
gel. The marked differences in 2D gel electrophoretic
spot patterns observed between the CS, PM and MT
fractions indicated that the procedure used for cardiac
tissue fractionation was good enough to separate differ-
ent cellular compartments (Figure 2A, B, and 2C). Our
next comparative image analysis of 2D maps prepared
from cardiac fractions of morphine-treated and control
rats revealed 12 differentially expressed protein spots
(Figure 2D). Only spots which had over two-fold
changes in density were classified as down- or up-regu-
lated. The average difference in spot densities within
control groups was about 20%. Two-fold changes in
density can thus be considered sufficient to determine
altered proteins. Whereas 4 of these significantly altered
s p o t sw e r ef o u n di nt h eC Sf r a c t i o n s ,t h eo t h e r8w e r e
in the PM fractions. Interestingly, no significant changes
were observed in 2D maps prepared from the MT frac-
tions. All the altered proteins were subsequently identi-
fied by mass spectrometry.
Identification of differentially expressed proteins
Protein spots showing altered abundance levels were
excised from the gel, in-gel digested with trypsin, and
analyzed by MALDI-TOF MS/MS as described pre-
viously [16]. Peptide mass-fingerprinting and subsequent
database searching revealed the identity of altered pro-
t e i n sa ss u m m a r i z e di nT a b l e1 .A sc a nb es e e nf r o m
the table, only one of all the identified proteins was
down-regulated (mitochondrial precursor of aldehyde
dehydrogenase) while all the others were up-regulated
to different extent. Two of the altered proteins (heat
shock protein beta-1 and hypoxia up-regulated protein
1) occured with multiple forms differing in gel mobility.
This likely reflects different post-translational modifica-
tions of these proteins, which have been previously
described [19,20].
The role of differentially expressed proteins
Aldehyde dehydrogenases (ALDHs) are important
enzymes that eliminate toxic aldehydes by catalyzing
Figure 1 Distribution of marker proteins in fractionated
samples of cardiac tissue. Protein samples (30 μg) of the
postnuclear supernatant (PNS), cytosolic (CS), plasma membrane-
enriched (PM) and mitochondrial (MT) fractions were subjected to
immunoblotting with antibodies against lactate dehydrogenase
(LDH), the a subunit of Na, K-ATPase, and F1-ATPase.
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a role in combating oxidative stress by reducing the cel-
lular ‘aldehydic load’ [21]. However, Wang et al. [22]
recently reported that the level of ADH 2 is significantly
down-regulated under oxidative stress conditions. Our
present finding of decreased level of mitochondrial pre-
cursor of ADH in myocardial preparations from mor-
phine-treated rats conforms well to the latter
observation, because it is known that chronic exposure
to morphine can induce oxidative stress in various tis-
sues [23,24].
Phosphatidylinositol transfer proteins (PITPs) are
responsible for the transport of phosphatidylinositol and
other phospholipids between membranes, and they par-
ticipate in many cellular processes including signaling,
lipid metabolism and membrane traffic [25]. It might be
speculated that the increased level of the a isoform of
PITP in morphine-exposed hearts can perhaps promote
Figure 2 Two-dimensional protein profiles of myocardial tissue. Representative gel images of the cytosolic (A), plasma membrane-enriched
(B) and mitochondrial (C) fractions stained with SYPRO Ruby are displayed. The positions of molecular weight markers are indicated to the left
and the pI at the bottom of each panel. The protein spots with markedly different densities in myocardial preparations from control and
morphine-treated rats are numbered from 1 to 12 and the respective portions of 2D gels are shown in greater magnification in panel D. The
corresponding identifications are listed in Table 1. Two spots were detected for heat shock protein beta-1 (No. 3 and 4) and three spots for
hypoxia up-regulated protein 1 (No. 5-7), possibly due to post-translational modifications.
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mentioned signaling processes. Phosphatidylinositol
transfer activities of PITPs have been shown to be
required for both PLC- and PI3K-mediated signaling
[26,27], and the activity of these two signaling pathways
is thought to play an important role in the development
of a cardioprotective phenotype [28,29]. It might be
worth mentioning in this context that morphine has
been reported as an agent capable to induce cardiopro-
tection under certain conditions [4-6].
Nevertheless, a major role in cytoprotection can be
attributed to the set of heat shock proteins (HSPs),
which function to limit protein aggregation, facilitate
protein refolding and chaperone other proteins [30].
H S P 2 7( h e a ts h o c kp r o t e i nb e t a - 1 )a n dH S C 7 0( h e a t
shock cognate 71 kDa protein) can be up-regulated
under oxidative stress conditions [31,32], and, intrigu-
ingly, the levels of both these proteins were significantly
elevated in cardiac preparations from morphine-treated
rats. These data comply with the notion that morphine
can cause oxidative stress. In line with this are also the
observed increased levels of ORP150 (hypoxia up-regu-
lated protein 1) and GRP78 (78 kDa glucose-regulated
protein), two chaperone molecules previously shown to
be up-regulated by endoplasmic reticulum stress [20,33].
These two proteins serve important cytoprotective func-
tions and can be up-regulated after numerous cellular
insults. The increased expression of all the above cyto-
protective proteins after prolonged morphine treatment
was confirmed by immunoblot analysis (Figure 3). These
results suggest that morphine administration can trigger
stress response in cardiomyocytes and that the levels of
intracellular heat shock and other stress-related proteins
increase in order to provide cellular protection and
maintain homeostasis under these conditions.
Changes found in the expression of two cytoskeletal/
contractile proteins, desmin and cardiac muscle alpha
actin 1, may imply that prolonged morphine treatment
could modulate formation of muscle fibres and muscle
contraction. Previous data indicated that the cytoskele-
ton, together with contractile proteins, is a major site of
the cellular damage and impairment of myocyte func-
tion in heart failure, and significant increase in these
proteins, including desmin and alpha-cardiac actin, has
been described in myocyte hypertrophy and failing
hearts [34,35]. These proteins play important roles in
cardiac integrity and contractility, but the consequences
of their up-regulation are not quite clear.
T h em a j o rv a u l tp r o t e i n( M V P )i ss u p p o s e dt ob e
involved in different cellular processes, including intra-
cellular signaling, cell survival, and differentiation and it
can play a protective role against some xenobiotics and
other stresses [36]. Our present finding of increased
expression of this protein after morphine exposure may
thus suggest that MVP could participate in mediating the
presumed cardioprotective effects of this drug. Recently
published data by Ikeda et al. [36] indicate that the PI3K/
Akt pathway might be implicated in the cytoprotective
effect of MVP. Interestingly, the protective function of
PI3K signaling could be synergistically enhanced also by
the observed increase of PITP expression.
Verification of the specificity of morphine effects
To determine whether the alterations observed in some
cytoprotective proteins (ORP150, HSP27, HSC70 and
GRP78) were induced by morphine or drug withdrawal,
a set of experiments was performed using a group of
animals, which were treated with morphine (10 mg/kg
per day) for 10 days and then withdrawn for 3 days. As
s h o w ni nF i g u r e4 ,t h e3 - d a ym o r p h i n ew i t h d r a w a l
resulted in normalization of protein expression to con-
trol levels. These results indicate that the increase in the
expression of cytoprotective proteins induced by mor-
phine exposure can be reversed by the drug withdrawal.
Table 1 List of cardiac proteins with significantly altered expression after prolonged morphine treatment




1 Aldehyde dehydrogenase, mitochondrial precursor ALDH2_RAT 6.63 56.5 74 ↓ 3.3
2 Phosphatidylinositol transfer protein, alpha isoform PIPNA_RAT 5.96 31.9 189 ↑ 2.3
3 Heat shock protein beta-1 HSPB1_RAT 6.12 22.9 152 ↑ 3.5
4 Heat shock protein beta-1 HSPB1_RAT 6.12 22.9 373 ↑ 5.2
5 Hypoxia up-regulated protein 1 HYOU1_RAT 5.11 111.3 69 ↑ 3.1
6 Hypoxia up-regulated protein 1 HYOU1_RAT 5.11 111.3 88 ↑ 3.3
7 Hypoxia up-regulated protein 1 HYOU1_RAT 5.11 111.3 65 ↑ 3.1
8 Major vault protein MVP_RAT 5.42 95.8 66 ↑ 5.3
9 78 kDa glucose-regulated protein GRP78_RAT 5.07 72.3 95 ↑ 3.2
10 Heat shock cognate 71 kDa protein HSP7C_RAT 5.37 70.9 59 ↑ 2.3
11 Desmin DESM_RAT 5.21 53.5 391 ↑ 4.3
12 Actin, alpha cardiac muscle 1 ACTC_RAT 5.23 42.0 160 ↑ 2.6
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changes could have been mediated by signaling path-
ways independent of opioid receptor activation, the
opioid antagonist naloxone was employed in subsequent
experiments [37]. Naloxone alone or a combination of
naloxone and morphine was administered to rats and
the levels of selected cytoprotective proteins in
myocardial preparations were assessed by immunoblot-
ting (Figure 5). Naloxone did not alter expression of
these proteins and the effect of morphine was comple-
tely blocked by this compound. These observations
allow us to conclude that morphine exerted its effects
through the activation of opioid receptors and its action
was specific.
Figure 3 Immunoblot analysis of cytoprotective proteins in myocardial preparations from rats affected by morphine exposure.
Samples from control (CON) and morphine-treated (MOR) rats were resolved by SDS-PAGE, transferred to nitrocellulose membrane and probed
with indicated antibodies. All lanes were loaded with 50 μg proteins. The relative levels of ORP150, hypoxia up-regulated protein 1 (A), HSP27,
heat shock protein beta-1 (B), HSC70, heat shock cognate 71 kDa protein (C) and GRP78, 78 kDa glucose-regulated protein (C) were assessed by
scanning densitometry.
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In this study, we adopted a proteomics-based approach
to investigate the effect of morphine exposure on car-
diac protein expression. Our results demonstrate that
10-day high dose morphine treatment altered the
expression of several important proteins that are
involved in anti-oxidative defence or cytoprotection, sig-
naling, and cytoskeletal/contractile structures. These
data indicate for the first time that morphine can induce
a wide range of effects in the heart and future studies
will involve exploring the function and regulation of
these proteins in more detail.
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